Safety, tolerability and clinical implementation of 'ready-to-use' (68)gallium-DOTA0-Tyr3-octreotide ((68)Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
Authors
Manoharan, PrakashLamarca, Angela
Navalkissoor, S
Calero-Valdayo, Juan
Chan, PS
Julyan, Peter J
Sierra, M
Caplin, M
Valle, Juan W
Affiliation
The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, UKIssue Date
2020
Metadata
Show full item recordCitation
Lees-Deutsch L, Gough B, Yorke J, Caress AL. Patient and Caregiver Experience of Hospital Discharge from an Acute Medicine Unit via the Discharge Lounge: A Qualitative Case Study. Acute Med. 2020;19:26-33Journal
ESMO OpenDOI
10.1136/esmoopen-2019-000650PubMed ID
32188715Additional Links
https://dx.doi.org/10.1136/esmoopen-2019-000650Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/esmoopen-2019-000650